PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of dibGuide for AuthorsAboutExplore this JournalData in Brief
 
Data Brief. 2018 February; 16: 334–340.
Published online 2017 November 20. doi:  10.1016/j.dib.2017.11.050
PMCID: PMC5723262

The dataset describes: Phenotypic changes induced by cholesterol loading in smooth muscle cells isolated from the aortae of C57BL/6 mice

Abstract

The data presented in this article is related to the research article entitled “ABCA1 and HDL3 are Required to Modulate Smooth Muscle Cells Phenotypic Switch after Cholesterol Loading (Castiglioni et al., 2017) [1]. This data describes the characterization of the phenotypic changes induced by cholesterol loading in smooth muscle cells (SMCs) isolated from the aortae of C57BL/6 mice. Upon cholesterol loading, there is a significant and concentration-dependent decrease in the expression of Acta2 and a parallel increase in Mac-2, and ATP binding cassette (ABC) transporters Abca1 and Abcg1. Cholesterol incubation causes the transformation of SMCs into foam cells with a 3-fold increase in cellular total cholesterol content and a 2.5-fold stimulation of the activity of the esterifying enzyme Acyl-CoA:cholesterol acyltransferase (ACAT). The addition of the same amount of cholesterol, either dissolved in ethanol or as lipoprotein cholesterol (AcLDL or native LDL) only slightly induces the activity of the enzyme ACAT, and does not cause the accumulation of lipid droplets into SMCs. We describe also the knock down of ABCA1 expression by siRNA treatment in mouse smooth muscle cells.

Keywords: ABCA1, Cholesterol, HDL3, Phenotypic switch, Smooth muscle cells

Specifications Table

Table thumbnail

Value of the data

  • • This data describes the cholesterol-induced phenotypic changes in murine smooth muscle cells.
  • • Cholesterol loading downregulates the expression of smooth muscle cell markers, and increases the expression of inflammation-related genes. In addition, cholesterol transforms smooth muscle cells into foam cells and affects lipid metabolism.
  • • The present data gives insights on how deliver cholesterol to metabolically active intracellular lipid pools, independently of lipoprotein receptor pathway.

1. Data

This dataset extends and completes the data presented in the recently published article [1]. Cholesterol loading of smooth muscle cells (SMCs) isolated from the aortae of C57BL/6 mice causes a significant and concentration-dependent decrease in Acta2 mRNA levels (Fig. 1A) and an increase in Mac-2, Abca1 and Abcg1 mRNA (up to 10-fold, 16-fold and 160-fold, respectively). The effects on mRNAs are confirmed by western blot analysis (Fig. 1B). Cholesterol incubation causes the transformation of SMCs into foam cells, with intracellular accumulation of lipid droplets (Oil Red O staining; Fig. 2A). There is a 3-fold increase in cellular total cholesterol content, due to the accumulation of both free and esterified cholesterol (Fig. 2B). The increased cellular esterified cholesterol content is caused by a 2.5-fold stimulation of the activity of the esterifying enzyme ACAT that is completely blocked by the addition of Sandoz 58-035, a specific ACAT inhibitor (Fig. 3A). The addition of the same amount of cholesterol, either dissolved in ethanol or as lipoprotein cholesterol (native low-density lipoprotein (LDL) or Acetylated LDL) slightly induces the activity of the ACAT enzyme (Fig. 3A), and does not cause the accumulation of lipid droplets into SMCs (data not shown). The cholesterol delivered is available for downloading in the presence of HDL3 (Fig. 3B).

Fig. 1
Effects of cholesterol-loading on mRNA and protein expression in SMC. SMCs isolated from C57BL/6 mice were treated with increasing concentrations of Chol:MβCD in DMEM 0.2% EFAF. After 48 h, total mRNA and proteins were extracted and subjected ...
Fig. 2
Cholesterol loading induces the accumulation of lipids in C57BL/6 SMCs. (A) Mouse SMCs were treated with Chol:MβCD (50 μg/mL) in DMEM 0.2% EFAF. After 48 h cells were fixed in 4% paraformaldehyde, stained with Oil Red O ...
Fig. 3
Effect of lipoprotein or non-lipoprotein cholesterol on cholesterol esterification in murine SMCs. (A) C57BL/6 mice SMCs were treated for 48 h with cholesterol (50 μg/mL) added as Chol:MβCD, dissolved in ethanol or as lipoproteins ...

As shown in Fig. 4, the incubation of WT SMC with Abca1 siRNA reduces Abca1 expression to the levels observed in Abca1 KO cells, as measured by either qRT-PCR or western blot analysis (Fig. 4).

Fig. 4
Effect of Abca1 siRNA treatment on Abca1 expression. WT SMCs were treated for 24 h with 10 nM Abca1 siRNA or a nonsense strand of siRNA (scramble). Then cells were treated for 48 h with Chol:MβCD (50 μg/mL) ...

2. Experimental design, materials and methods

2.1. Cell cultures

SMCs were isolated from the intimal-medial layer of aortae of littermate Abca1 WT and KO mice of both sexes (The Jackson Lab, Bar Harbor, ME, USA). The mice, originally on a DBA background, have been backcrossed into C57BL/6 mice for at least nine times. All mice were kept in accordance with guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes and the Italian Ministry of Health and the local University of Milan ethics committee approved the protocol. Mice were anesthetized with 2% isoflurane and killed by cervical dislocation. Aorta was rapidly dissected from the aortic root to the iliac bifurcation and SMCs prepared according to the procedure described by Ross [2].

Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% FCS. The medium was changed every three days. SMC lineage was confirmed by the presence of immunoreactivity for Acta2 in > 99% of the cells. The experiments have been performed using 8 cell lines isolated from different mice of both genotypes. Cells were used between the 4th and 10th passage.

2.2. HDL3 isolation

HDL3 were isolated from the plasma of healthy normolipidemic volunteers by sequential preparative ultracentrifugation [3].

2.3. Cell treatment

Cholesterol was delivered to cells by using a Chol:MβCD complex as ‘‘water-soluble cholesterol’’ containing ≈ 50 mg of cholesterol/g solid (molar ratio, 1:6 cholesterol/MβCD, Sigma-Aldrich) [4], [5]. All treatment concentrations involving Chol:MβCD were based on cholesterol weight. SMCs were incubated with DMEM supplemented with 0.2% Essential Fatty Acid Free albumin alone or containing Chol:MβCD (50 µg/ml) or HDL3 (100 µg/ml) or apoAI (35 µg/ml) for 48 h.

2.4. Oil Red O staining

Cholesterol-loaded SMCs were fixed for 30 min with 4% paraformaldehyde solution in PBS, stained with Oil Red O for 4 h and counterstained with hematoxylin for other 5 min [6]. Cells were examined with a light microscope (X80) and pictures of representative fields were taken.

2.5. Cholesterol esterification

After cholesterol loading, 14C-oleic acid was added and cholesterol esterification measured following the incorporation of labelled oleate into cellular cholesteryl esters [7].

2.6. Extraction and analysis of cellular cholesterol

Cell lipids were extracted in hexane/isopropyl alcohol (3:2) containing BHT 0.01%. Free- and esterified cholesterol were separated by HPTLC plates and quantified on a DANI 1000 gas liquid chromatographer [8]. Results were normalized by protein content.

2.7. mRNA and miRNA levels measurement

Total RNA was extracted by using the TRIZOL solution (Invitrogen) according to manufacturer's protocol and reverse transcribed (Thermo Scientific). SYBR Green-based real time PCR was used to measure mRNA or miRNA levels [9]. The primers used for specific mouse genes are listed in Table 1.

Table 1
Sequences of mouse primers.

2.8. siRNA treatment

Wild type SMCs were transfected for 24 h with Abca1 siRNA (ON-TARGETplus SMARTpool Mouse Abca1, Dharmacon) or a nonsense strand of siRNA (scramble, ON-TARGETplus Non-Targeting pool, Dharmacon), using INTERFERin siRNA transfection reagent (Polyplus). Then, cells were treated for 48 hours with Chol:MβCD (50 μg/mL) in presence or absence of HDL3 (100 μg/mL). Total mRNA was extracted and subjected to qRT-PCR analysis.

2.9. Western blot

Mouse SMCs were processed for Western blotting as described [9]. The different proteins were detected using the following primary antibodies: Abca1 (1:1000; Abcam), Abcg1 (1:500; Novus Biologicals), Acta2 (1:10,000; Abcam), Mac-2 (1:1000: Abcam), β-actin (1:5000; Sigma-Aldrich), α-tubulin (1.5000; Sigma-Aldrich). Quantification was performed by densitometric analysis using the Image Studio Lite software from Li-Cor Bioscience.

2.10. Statistical analysis

Data were expressed as means ± SD. All experiments were repeated at least four-five times in triplicates.

Acknowledgements

None.

Footnotes

Transparency documentTransparency document associated with this article can be found in the online version at https://doi.org/10.1016/j.dib.2017.11.050

Transparency document. Supplementary material

Transparency document

References

1. Castiglioni S., Monti M., Arnaboldi L. ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading. Atherosclerosis. 2017;266:8–15. [PubMed]
2. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J. Cell Biol. 1971;50:172–186. [PubMed]
3. Beitz J., Corsini A., Bellosta S. Influence of trapidil and derivatives on cholesterol synthesis and esterification in cultured cells. Pharmacol. Res. 1991;24:235–242. [PubMed]
4. Rong J.X., Shapiro M., Trogan E. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. USA. 2003;100:13531–13536. [PubMed]
5. Vengrenyuk Y., Nishi H., Long X. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler. Thromb. Vasc. Biol. 2015;35:535–546. [PubMed]
6. Monetti M., Canavesi M., Camera M. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacol. Res. 2007;55:441–449. [PubMed]
7. Bernini F., Didoni G., Bonfadini G. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages. Atherosclerosis. 1993;104:19–26. [PubMed]
8. Zoja C., Corna D., Gagliardini E. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am. J. Physiol. Ren. Physiol. 2010;299:F1203–F1211. [PubMed]
9. Giunzioni I., Bonomo A., Bishop E. Cigarette smoke condensate affects monocyte interaction with endothelium. Atherosclerosis. 2014;234:383–390. [PubMed]

Articles from Data in Brief are provided here courtesy of Elsevier